Axoltis Pharma’s Post

Axoltis Pharma reposted this

🌟 **Meet Axoltis Pharma !** 🌟 Axoltis Pharma is thrilled to announce our participation in the upcoming 35th International Symposium on ALS/MND in Montreal, Canada (December 6-8, 2024). Dr Annette Janus, MD, Chief Medical Officer, is glad to attend and to present "NX210c for recovering Blood Brain Barrier integrity in ALS patients in silico modelling complements statistical analysis of fluid biomarkers for dose selection and design of a phase II study (SEALS)" on Saturday December 7th 5:30pm EST – Poster session   This International Symposium is the biggest annual conference dedicated to ALS and MND research. Each year it brings together researchers from around the world to share new understanding of amyotrophic lateral sclerosis and motor neurone disease.   #BBB #drugcandidate #neurodegenerativedisease #axoltispharma #InSilicoTrials #ARSLA #DONSLIA #NX210c #ALS #SLA

Josselin LE GALL

Board Director/Advisor | Customer Experience (CX) | Corporate Social Response (CSR) | Crisis management & Emergency response | Community engagement | Multicultural divers. | Intrnatl Relations | NonProfit Organisations.

1mo

Is there a weblink to watch the symposium on line or will it be recorded? ARSLA Olivier Goy Les Invincibles

Grant Smillie

🧠 Building neuroscience teams one hire at a time

1mo

Have a good conference team 👏

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics